Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

[Circulating tumor cells: a new challenge for laboratory medicine].

Séronie-Vivien S.

Ann Biol Clin (Paris). 2014 Mar-Apr;72(2):153-77. doi: 10.1684/abc.2014.0945. Review. French.

2.

Urinary cystatin C can improve the renal safety follow-up of tenofovir-treated patients.

Jaafar A, Séronie-Vivien S, Malard L, Massip P, Chatelut E, Tack I.

AIDS. 2009 Jan 14;23(2):257-9. doi: 10.1097/QAD.0b013e328314e382.

PMID:
19098496
3.

Population pharmacokinetics and pharmacogenetics of imatinib in children and adults.

Petain A, Kattygnarath D, Azard J, Chatelut E, Delbaldo C, Geoerger B, Barrois M, Séronie-Vivien S, LeCesne A, Vassal G; Innovative Therapies with Children with Cancer European consortium.

Clin Cancer Res. 2008 Nov 1;14(21):7102-9. doi: 10.1158/1078-0432.CCR-08-0950.

4.

Cystatin C: current position and future prospects.

Séronie-Vivien S, Delanaye P, Piéroni L, Mariat C, Froissart M, Cristol JP; SFBC "Biology of renal function and renal failure" working group.

Clin Chem Lab Med. 2008;46(12):1664-86. doi: 10.1515/CCLM.2008.336. Review.

5.

[Cystatin C: current step and future prospects].

Séronie-Vivien S, Delanaye P, Pieroni L, Mariat C, Froissart M, Cristol JP; Groupe de travail "Biologie des fonctions rénales et de l'insuffisance rénale" de la SFBC.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):301-23. doi: 10.1684/abc.2008.0227. Review. French.

6.

[Evaluation of renal function: an update].

Froissart M, Delanaye P, Séronie-Vivien S, Cristol JP; Groupe de travail "Biologie des fonctions rénales et de l'insuffisance rénale" de la SFBC.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):269-75. doi: 10.1684/abc.2008.0228. French.

7.

[Consequences for clinical biochemists of the modifications of the creatinine-based evaluation of glomerular filtration rate between 2005 and 2008].

Séronie-Vivien S, Pieroni L, Galteau MM, Carlier MC, Hanser AM, Cristol JP; Groupe de travail "Biologie des fonctions rénales et de l'insuffisance rénale" de la SFBC.

Ann Biol Clin (Paris). 2008 May-Jun;66(3):263-8. doi: 10.1684/abc.2008.0226. French.

8.

Modeling the variability of creatinine measurements improves estimates of the glomerular filtration rate.

Séronie-Vivien S, Bouissou F, Dattez S, Coulais Y, Hanser AM, Hym B, Chatelut E.

Clin Chem Lab Med. 2008;46(2):215-8.

PMID:
18076358
9.

[Interest of cystatin C for individual dosing of anticancer drugs cleared by the kidneys].

Thomas F, Séronie-Vivien S, Malard L, Chatelut E.

Therapie. 2007 Mar-Apr;62(2):121-7. Epub 2007 Jun 21. French.

PMID:
17582313
10.

[Biology of renal functions and renal insufficiency].

Cristol JP; Biologie des Fonctions Rénales et de l'Insuffisance Rénale; Société Française de Biologie Clinique, Seronie-Vivien S, Sternberg M, Cavalier E, Blanchecotte F, Hanser AM, Pieroni L, Galteau MM, Monge M, Boutten A, Desch G, Ait Djafer Z, Carlier MC, Barguil Y, Terrier N, Guerber F, Souberbielle JC, Delmas Y, Delanaye P, Panescu V, Rossert J, Fouqueray B, Houillier P, Froissart M, Lefebvre HP, Canaud B, Halimi JM.

Ann Biol Clin (Paris). 2006 Nov-Dec;64(6):608-11. French. No abstract available.

11.

Pharmacokinetic-pharmacodynamic relationships of imatinib and its main metabolite in patients with advanced gastrointestinal stromal tumors.

Delbaldo C, Chatelut E, Ré M, Deroussent A, Séronie-Vivien S, Jambu A, Berthaud P, Le Cesne A, Blay JY, Vassal G.

Clin Cancer Res. 2006 Oct 15;12(20 Pt 1):6073-8.

12.

GFR is better estimated by considering both serum cystatin C and creatinine levels.

Bouvet Y, Bouissou F, Coulais Y, Séronie-Vivien S, Tafani M, Decramer S, Chatelut E.

Pediatr Nephrol. 2006 Sep;21(9):1299-306. Epub 2006 Jun 22.

PMID:
16794818
13.

Contribution of the MDRD equation and of cystatin C for renal function estimates in cancer patients.

Séronie-Vivien S, Toullec S, Malard L, Thomas F, Durrand V, Chatelut E.

Med Oncol. 2006;23(1):63-73.

PMID:
16645231
14.

Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.

Goffinet M, Thoulouzan M, Pradines A, Lajoie-Mazenc I, Weinbaum C, Faye JC, Séronie-Vivien S.

BMC Cancer. 2006 Mar 15;6:60.

15.

Cystatin C as a new covariate to predict renal elimination of drugs: application to carboplatin.

Thomas F, Séronie-Vivien S, Gladieff L, Dalenc F, Durrand V, Malard L, Lafont T, Poublanc M, Bugat R, Chatelut E.

Clin Pharmacokinet. 2005;44(12):1305-16.

PMID:
16372828
16.

Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum.

Séronie-Vivien S, Galteau MM, Carlier MC, Hadj-Aissa A, Hanser AM, Hym B, Marchal A, Michotey O, Pouteil-Noble C, Sternberg M, Perret-Liaudet A; Creatinine Working Group of the Société Française de Biologie Clinique.

Clin Chem Lab Med. 2005;43(11):1227-33.

PMID:
16232080
17.

Serum cystatin C is a better marker of topotecan clearance than serum creatinine.

Hoppe A, Séronie-Vivien S, Thomas F, Delord JP, Malard L, Canal P, Chatelut E.

Clin Cancer Res. 2005 Apr 15;11(8):3038-44.

18.

A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer.

Séronie-Vivien S, Dalenc F, Balaguer P, Nicolas JC, Roché H, Faye JC.

Clin Chem Lab Med. 2004;42(8):889-95.

PMID:
15387438
19.

[Improving the interlaboratory variation for creatinine serum assay].

Séronie-Vivien S, Galteau MM, Carlier MC, Hadj-Aissa A, Hanser AM, Hym B, Marchal A, Michotey O, Pouteil-Noble C, Sternberg M, Perret-Liaudet A; SFBC "Créatinine" de la Section "Assurance qualité".

Ann Biol Clin (Paris). 2004 Mar-Apr;62(2):165-75. French.

20.

Supplemental Content

Loading ...
Support Center